Phase 1 trial of ralimetinib (LY2228820) with radiotherapy plus concomitant temozolomide in the treatment of newly diagnosed glioblastoma.
Biau J, Thivat E, Chautard E, Stefan D, Boone M, Chauffert B, Bourgne C, Richard D, Molnar I, Levesque S, Bellini R, Kwiatkowski F, Karayan-Tapon L, Verrelle P, Godfraind C, Durando X.
Biau J, et al. Among authors: chautard e.
Radiother Oncol. 2021 Jan;154:227-234. doi: 10.1016/j.radonc.2020.09.036. Epub 2020 Sep 22.
Radiother Oncol. 2021.
PMID: 32976869
Clinical Trial.